Format

Send to

Choose Destination
Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017.

Reverse vaccinology: developing vaccines in the era of genomics.

Author information

1
La Jolla Institute for Allergy and Immunology, San Diego, CA 92130, USA.

Abstract

The sequence of microbial genomes made all potential antigens of each pathogen available for vaccine development. This increased by orders of magnitude potential vaccine targets in bacteria, parasites, and large viruses and revealed virtually all their CD4(+) and CD8(+) T cell epitopes. The genomic information was first used for the development of a vaccine against serogroup B meningococcus, and it is now being used for several other bacterial vaccines. In this review, we will first summarize the impact that genome sequencing has had on vaccine development, and then we will analyze how the genomic information can help further our understanding of immunity to infection or vaccination and lead to the design of better vaccines by diving into the world of T cell immunity.

PMID:
21029963
PMCID:
PMC3320742
DOI:
10.1016/j.immuni.2010.09.017
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center